Risk models predicting survival after reduced-intensity transplantation for myelofibrosis-Reference-Cited by-同舟云学术

Risk models predicting survival after reduced-intensity transplantation for myelofibrosis

Published:2012-01-27 Issue:1 Volume:157 Page:75-85
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Alchalby Haefaa,Yunus Dinah-Rohina,Zabelina Tatjana,Kobbe Guido,Holler Ernst,Bornhäuser Martin,Schwerdtfeger Rainer,Bethge Wolfgang,Kvasnicka Hans Michael,Büsche Guntram,Ayuk Francis,Bacher Ulrike,Zander Axel. R.,Kröger Nicolaus

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2011.09009.x/fullpdf

Reference23 articles.

1. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis;Alchalby;Blood,2010

2. Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type;Bacigalupo;Bone Marrow Transplantation,2010

3. Outcome of transplantation for myelofibrosis;Ballen;Biol Blood Marrow Transplant,2010

4. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups;Cervantes;British Journal of Haematology,1998

5. Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders;Cervantes;Leukemia,2008

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-08

2. Myelofibrosis and allogeneic transplantation: critical points and challenges;Frontiers in Oncology;2024-06-20

3. Introduction on Stem Cell Therapy and Regeneration;Comprehensive Hematology and Stem Cell Research;2024

4. Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET/PV Myelofibrosis;Cancer Consult;2023-11-18

5. Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes;Frontiers in Oncology;2023-08-10